𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: The effect of smoking

✍ Scribed by T. R. Norman; A. Fulton; G. D. Burrows; K. P. Maguire


Publisher
Springer
Year
1981
Tongue
English
Weight
461 KB
Volume
21
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of smoking on single dose pharmac
✍ A. Mirfazaelian; F. Jahanzad; M. Tabatabaei-far; H. Farsam; M. Mahmoudian πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## Abstract In order to determine interaction of smoking with single dose pharmacokinetics of phenobarbital, a 60 mg tablet of the drug was given to 12 healthy male subjects in two groups (6 smokers and 6 non‐smokers) in a double blind study. An HPLC method using UV detection was developed to asses

Pharmacokinetics of tiaprofenic acid in
✍ L. Bertin; E. Rey; G. Pons; J. L. Mathiot; M. O. Richard; P. ChrΓ©tien; C. Saint- πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 251 KB

Twelve healthy children in three age groups anaesthetized for minor surgery were given a single oral dose of tiaprofenic acid (3 mg.kg-1) (TA). Seven blood samples and zero to 8 and 8 to 24 h urines were collected. TA concentrations in plasma and urine were measured by HPLC. No significant differenc

Pharmacokinetics after a single oral dos
✍ G. Wensing; R. A. Branch; H. Humbert; E. E. Ohnhaus; W. Kirch πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 396 KB

The plasma concentration-time curve of the hydrolysis product of bopindolol has been investigated in 14 patients with cirrhosis and in 15 healthy volunteers given a single oral dose of 2 mg bopindolol. Cirrhosis was confirmed by history and clinical examination or liver biopsy. The time to maximum c

Clinical pharmacokinetics of procaterol:
✍ Dr Michael A. Eldon; Debbie S. Blake; Michael J. Coon; Gerald D. Nordblom; Allen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Procaterol is a potent, orally active &-agonist bronchodilator useful in the treatment of reversible bronchospastic disease. It is effective when administered as single or multiple (Q8H) 50 and 75pg doses. As part of the clinical development of procaterol, the pharmacokinetics and dose proportionali